Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 February 2006, Vol. 107, No. 4, pp. 1248-1249.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Newman, P. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Newman, P. J.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow


InsideBlood

HEMOSTASIS

Comment on Inoue et al, page 1405

New role for the GPVI/FcR{gamma} chain complex

Peter J. Newman

BLOOD RESEARCH INSTITUTE, BLOODCENTER OF WISCONSIN

Previously thought to function only in collagen-induced platelet activation, Inoue and colleagues report that the GPVI/FcR{gamma} chain complex is a crucial component in relaying activation signals following platelet exposure to the extracellular matrix protein laminin.

Interaction of resting platelets with exposed components of the subendothelial matrix is an important "sentry" event that takes place early on at sites of vascular injury. Depending on the nature and extent of damage, platelets can encounter a variety of fibrous proteins, including laminin, fibronectin, and collagen, as well as the collagen-bound adhesive protein von Willebrand factor (VWF). To be able to respond to such a diverse array of extracellular matrix components, platelets have been endowed with a host of receptors, each specific for different matrix constituents. Thus, the GPIb complex and the integrin {alpha}IIbbeta3 bind to different regions on immobilized VWF, while the integrins {alpha}5beta1, {alpha}IIbbeta3, {alpha}2beta1, and {alpha}6beta1 interact with fibronectin, collagen, and laminin, respectively.


Figure 1
Receptors for 2 different extracellular matrix proteins use the GPVI/FcR{gamma} chain complex for signal transduction. Upon binding of laminin to integrin {alpha}6beta1 (blue, left) or of collagen to integrin {alpha}2beta1 (pink, right), tyrosine residues within the ITAMs of the FcR{gamma} chain signaling subunit of the GPVI/FcR{gamma} chain complex become phosphorylated, recruit the Syk tyrosine kinase, and assemble a signaling complex that activates phospholipase C{gamma}2 (PLC{gamma}2). Activation of PLC{gamma}2 ultimately results in cytokskeletal changes, granule secretion, and activation of cell-surface integrins involved in platelet-matrix and platelet-platelet interactions. This pathway was previously thought to operate exclusively in response to collagen and collagen-related snake venom peptides.

 
How the information that "contact has occurred" is transmitted to the platelet interior is an increasingly active and important area of platelet signal transduction research.1 GPIb/VWF interactions serve mainly to tether the platelet to the damaged vessel wall, although relatively weak activation signals also emanate from the GPIb complex that potentiate downstream platelet activation. Responses to collagen, on the other hand, are considerably more vigorous and complex, being mediated by 2 different receptors: the integrin {alpha}2beta1 and a platelet-specific, heterotrimeric receptor composed of the Ig-superfamily member, GPVI, in noncovalent association with a homodimer of the FcR{gamma} chain.2 Upon binding collagen, signals emanating from {alpha}2beta1 and the GPVI/FcR{gamma} chain complex reinforce each other, ultimately leading to conformational changes in the major platelet integrin, {alpha}IIbbeta3, which in its activated state associates with bridging proteins like fibrinogen and VWF. Although the nature of {alpha}2beta1-mediated signals is not as well understood, numerous studies using GPVI-deficient mice, FcR{gamma} chain-deficient mice, and antibodies that either block the interaction of GPVI with collagen or deplete GPVI from the platelet surface, have shown that engagement of the GPVI/FcR{gamma} chain complex works via Src family kinase-mediated phosphorylation of specific immunoreceptor tyrosine-based inhibitory motifs (ITAMs) that are present on the cytoplasmic domain of the FcR{gamma} chain. These ITAMs, when phosphorylated, serve as docking sites for the protein-tyrosine kinase Syk, which, when recruited and activated, initiates the rapid assembly of a series of adaptor proteins and protein-tyrosine kinases that are crucial for platelet activation responses, including cytoskeletal rearrangements that mediate platelet shape change and spreading and coalescence and secretion of intracellular granules, as well as activation of additional adhesion receptors that are required for adhesion strengthening and thrombus formation to occur.

In 2003, Gruner and colleagues3 reported in this journal the somewhat surprising observation that platelets from {alpha}2beta1-deficient mice adhere quite normally to the wall of a ligation-injured murine carotid artery, and that their adhesion was only partially reduced when {alpha}IIbbeta3 was additionally blocked by a monoclonal antibody. When {alpha}IIbbeta3 was inhibited in murine platelets missing all 3 beta1 integrins ({alpha}2beta1, {alpha}5beta1, and {alpha}6beta1), however, adhesion and thrombus formation were absent, implicating {alpha}5beta1 and/or {alpha}6beta1 as integrins capable of mediating platelet-vessel wall interactions under conditions of arterial shear. Interestingly, GPVI was found to be indispensable for platelet adhesion and aggregation to occur, strongly suggesting that it might be involved in regulating platelet interactions with the vessel wall.

In this issue of Blood, Inoue and colleagues report the novel observation that the GPVI/FcR{gamma} chain complex, in addition to its crucial role as a collagen receptor, is also an important component of platelet activation following interaction of {alpha}6beta1 with laminin—a prominent component of the basal lamina that underlies epithelial and endothelial cell monolayers and also surrounds individual muscle cells. The interaction of GPVI with laminin was found to be too weak by itself to support adhesion; however, in conjunction with {alpha}6beta1, expression of the GPVI/FcR{gamma} chain complex strongly potentiated formation of lamellipodia, and to a lesser extent filopodia, during the platelet spreading process. Interestingly, platelet activation by laminin was found to enlist the signaling, rather than the adhesive, properties of the GPVI/FcR{gamma} chain complex, as both platelet spreading and tyrosine phosphorylation of several key downstream components of the GPVI/FcR{gamma} chain-mediated signaling were markedly reduced in FcR{gamma} chain-deficient platelets following their interaction with immobilized laminin.

Similar to the interplay between {alpha}2beta1 and the GPVI/FcR{gamma} chain complex following platelet interactions with collagen, the chicken-and-egg question as to whether (1) {alpha}6beta1 first binds laminin and presents it to the GPVI/FcR{gamma} chain for signaling to the cell interior, or (2) GPVI-laminin interactions first activate the {alpha}6beta1 integrin to facilitate platelet spreading, remains controversial. Both probably occur. Finally, since the GPVI/FcR{gamma} chain has now been identified as a central component of both collagen- and laminin-mediated platelet activation, it may be of future interest to determine whether the threshold for cellular activation in response to these prominent components of the extracellular matrix might be regulated by the same inhibitory signaling receptor.4 {blacksquare}

References

  1. Jackson SP, Nesbitt WS, Kulkarni S. Signaling events underlying thrombus formation. J Thromb Haemost. 2003;1: 1602-1612.[CrossRef][Medline] [Order article via Infotrieve]

  2. Chen H, Kahn ML. Reciprocal signaling by integrin and nonintegrin receptors during collagen activation of platelets. Mol Cell Biol. 2003;23: 4764-4777.[Abstract/Free Full Text]

  3. Gruner S, Prostredna M, Schulte V, et al. Multiple integrin-ligand interactions synergize in shear-resistant platelet adhesion at sites of arterial injury in vivo. Blood. 2003;102: 4021-4027.[Abstract/Free Full Text]

  4. Patil S, Newman DK, Newman PJ. Platelet endothelial cell adhesion molecule-1 serves as an inhibitory receptor that modulates platelet responses to collagen. Blood. 2001;97: 1727-1732.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Laminin stimulates spreading of platelets through integrin {alpha}6beta1–dependent activation of GPVI
Osamu Inoue, Katsue Suzuki-Inoue, Owen J. T. McCarty, Masaaki Moroi, Zaverio M. Ruggeri, Thomas J. Kunicki, Yukio Ozaki, and Steve P. Watson
Blood 2006 107: 1405-1412. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
BloodHome page
B. Boylan, C. Gao, V. Rathore, J. C. Gill, D. K. Newman, and P. J. Newman
Identification of Fc{gamma}RIIa as the ITAM-bearing receptor mediating {alpha}IIb{beta}3 outside-in integrin signaling in human platelets
Blood, October 1, 2008; 112(7): 2780 - 2786.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Newman, P. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Newman, P. J.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020